Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-008167)

Filing Details

Accession Number:: 0001209191-12-008167
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-02-07 16:45:45
Reporting Period:: 2012-01-17

Filing Date:: 2012-02-07
Accepted Time:: 2012-02-07 16:45:45
Original Submission Date:: 2012-01-19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1009356	Salix Pharmaceuticals Ltd	SLXP	Pharmaceutical Preparations (2834)	943267443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1212669	C Adam Derbyshire	8510 Colonnade Center Drive Raleigh NC 27615	Evp Finance/Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-18	375	$50.00	131,138	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares covered by this Form 4 have been sold pursuant to a Rule 10b5-1 Sales Plan dated December 2, 2011, which is intended to comply with Rule 10b5-1.
This Amendment is filed to correct the price per share for the shares of common stock sold on January 18, 2012, which was incorrectly stated in the initial Form 4 filed on January 19, 2012 as $4.0666 per share instead of $50.00 per share.